Formidable Asset Management, LLC Amgen Inc Transaction History

Formidable Asset Management, LLC

$609 Million
Q3 2024

A detailed history of Formidable Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Formidable Asset Management, LLC holds 7,085 shares of AMGN stock, worth $2 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

7,085

Previous 7,056 0.41%

Holding current value

$2 Million

Previous $2.2 Million 3.54%

% of portfolio

0.37%

Previous 0.37%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $8,972 - $9,784	29 Added 0.41%	7,085 $2.28 Million
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $158,963 - $193,182	605 Added 9.38%	7,056 $2.2 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $1.08 Million - $1.3 Million	4,018 Added 165.15%	6,451 $1.83 Million
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $47,304 - $53,365	-185 Reduced 7.07%	2,433 $700,000
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $13,774 - $17,101	63 Added 2.47%	2,618 $703,000
Q2 2023 Aug 15, 2023	BUY	$214.27 - $253.37 $4,928 - $5,827	23 Added 0.91%	2,555 $567,000
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $225 - $275	1 Added 0.04%	2,532 $618,000
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $229 - $291	1 Added 0.04%	2,531 $665,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $4,264 - $4,809	-19 Reduced 0.75%	2,530 $660,000
Q2 2022 Aug 16, 2022	BUY	$230.71 - $256.74 $52,832 - $58,793	229 Added 9.87%	2,549 $622,000
Q1 2022 May 04, 2022	SELL	$219.27 - $242.57 $12,279 - $13,583	-56 Reduced 2.36%	2,320 $561,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $8,949 - $10,242	45 Added 1.93%	2,376 $541,000
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $4,245 - $4,974	-20 Reduced 0.85%	2,331 $496,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $548,913 - $608,979	2,350 Added 235000.0%	2,351 $582,000
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $619,921 - $687,757	-2,654 Reduced 99.96%	1 $552,000
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $11,263 - $12,525	-48 Reduced 1.78%	2,655 $653,000
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $4,945 - $6,068	-25 Reduced 0.92%	2,703 $677,000
Q1 2020 Jun 01, 2020	SELL	$182.24 - $241.7 $63,784 - $84,595	-350 Reduced 11.37%	2,728 $553,000
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $582,388 - $748,569	3,078 New	3,078 $732,000
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $528,075 - $632,744	-3,033 Closed	0 $0
Q2 2019 Oct 15, 2019	SELL	$166.7 - $195.41 $1.6 Million - $1.88 Million	-9,617 Reduced 76.02%	3,033 $565,000
Q1 2019 Oct 15, 2019	BUY	$180.87 - $203.88 $2.29 Million - $2.58 Million	12,650 New	12,650 $54,000
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $648,828 - $724,939	-3,844 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $643,062 - $734,204	3,844	3,844 $716,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.

Account

Formidable Asset Management, LLC Amgen Inc Transaction History